Figure 2 summarizes the 24-hourpharmacokinetic profile of DHT for patients maintained on testosterone gel 50mg or testosterone gel 100 mg for 30 days. Figure 1 summarizes the 24-hourpharmacokinetic profile of testosterone for patients maintained on testosteronegel 50 mg or testosterone gel 100 mg for 30 days. Testosterone gel delivers physiologic amounts oftestosterone, producing circulating testosterone concentrations thatapproximate normal levels (e.g., 300 – 1000 ng/dL) seen in healthy men. There were no reports of overdose in the testosterone gelclinical trials. There is insufficient long-term safety data in geriatricpatients to assess the potentially increased risks of cardiovascular diseaseand prostate cancer see WARNINGS AND PRECAUTIONS. Although it is not known how much testosterone transfersinto human milk, Vogelxo is contraindicated in nursing women because of thepotential for serious adverse reactions in nursing infants. Secondary exposure to testosterone in children and womencan occur with the use of testosterone gel products in men.
Inmost cases, these signs and symptoms regressed with removal of the exposure totestosterone gel. In most cases with a reported outcome, thesesigns and symptoms were reported to have regressed with removal of thetestosterone gel exposure. The following adverse reactions have been identifiedduring post-approval use of testosterone gel products. In the combined U.S. andEuropean open label extension studies, approximately 140 patients receivedtestosterone gel for at least 6 months.
If any of these symptoms appear, it is critical to consult a healthcare provider immediately for further evaluation. Additionally, a comprehensive metabolic panel (CMP) can provide further insights into liver function and overall metabolic health. Although the risk is considered low, it is not negligible, and regular monitoring is advised.
RxList does not provide medical advice, diagnosis or treatment. There may be new information.This leaflet does not take the place of talking to your healthcare providerabout your medical condition or treatment. Read this Instructions for Use for Vogelxo before youstart using it and each time you get a refill. You can ask your pharmacist or healthcare provider forinformation about Vogelxo that is written for health professionals. Do not use Vogelxo for a condition forwhich it was not prescribed. General information about the safe and effective useof Vogelxo. Call your healthcare provider right away if you haveany of the serious side effects listed above.
The average daily DHTconcentration produced by testosterone gel 100 mg at Day 30 was 555 (± 293)pg/mL and by testosterone gel 50 mg at Day 30 was 346 (± 212) pg/mL. The average daily testosteroneconcentration produced by testosterone gel 100 mg at Day 30 was 612 (± 286)ng/dL and by testosterone gel 50 mg at Day 30 was 365 (± 187) ng/dL. In a single dose, replicate crossover study, when Vogelxo100 mg was applied, absorption of testosterone into the blood continued for theentire 24 hour dosing period. Alcohol-based products, including Vogelxo, are flammable;therefore, patients should be advised to avoid fire, flame or smoking until theVogelxo has dried.

Gender: Female

Social links